US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

249.65

-16.1400-6.07%

Post-market: 251.201.55+0.62%16:49 EDT

Volume:439.27K

Turnover:113.74M

Market Cap:567.83M

PE:- -

High:271.79

Open:261.76

Low:248.93

Close:265.79

52wk High:341.93

52wk Low:93.20

Shares:2.27M

Float Shares:2.27M

Volume Ratio:1.35

T/O Rate:19.31%

Dividend:0.90

Dividend Rate:0.36%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

AdAlta wins FDA pre‑IND meeting for lead CAR‑T cancer therapy EW‑001

Health Care up as Viking Surges - Health Care Roundup

TriSalus Life Sciences Gets FDA Clearance for Drug Delivery Device

Health Care Roundup: Market Talk

TriSalus Gains FDA Clearance for TriNav Advance Device

Quoin Gains FDA Fast Track for QRX003 Skin Therapy

Tenet Healthcare initiated with a Market Perform at BMO Capital

Tenet Healthcare Issues New Senior Notes to Refinance Debt

GE HealthCare Appoints Pascal Desroches to Board Committees

TriSalus Life Sciences receives FDA clearance for TriNav Advance

DRI Healthcare (DHT.UN) Receives a Buy from Stifel Nicolaus

Exchange-Traded Funds Rise, US Equities Mixed After Midday

MT Newswires Live

CMS cancels 315,000 unauthorized enrollments in federal health insurance market

Grail Gains From More Focused FDA Review Before Galleri Advisory Panel, UBS Says

MT Newswires Live

Health Care Roundup: Market Talk

Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN), Viking Therapeutics (VKTX) and Amgen (AMGN)

China Isotope & Radiation Gains FDA Clearance for Lu-177 Nuclear Medicine Ingredient

Filana can proceed with study as hold lifted, says Lucid Capital

Compass Therapeutics Faces FDA Pushback on Tovecimig Trial

Press Release: Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil(R) Development Amid Growing Federal Support for Botanical Drug Pathways

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/LABU/news?page=15"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":249.65,"timestamp":1790884800000,"preClose":265.79,"halted":0,"volume":439268,"hourTrading":{"tag":"盘后","latestPrice":251.2,"preClose":249.65,"latestTime":"16:49 EDT","volume":812,"amount":203902.04268,"timestamp":1790887771172,"change":1.55,"changeRate":0.006209,"amplitude":0.00701},"delay":0,"changeRate":-0.060724632228451085,"floatShares":2274486,"shares":2274486,"eps":0,"marketStatus":"Post-Mkt","change":-16.14,"latestTime":"10-01 16:52:58 EDT","open":261.76,"high":271.79,"low":248.93,"amount":113744310.69544001,"amplitude":0.086008,"askPrice":251.5,"askSize":50,"bidPrice":250.55,"bidSize":4,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790899200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":265.79,"sharesOutstanding":3074486,"nav":260.661,"aum":592869955.42,"dividendRate":0.00362,"bidAskSpread":0.003436,"preHourTrading":{"tag":"盘前","latestPrice":261.6,"preClose":265.79,"latestTime":"09:29 EDT","volume":2318,"amount":612617.1732800001,"timestamp":1790861345993,"change":-4.19,"changeRate":-0.015764,"amplitude":0.02976},"postHourTrading":{"tag":"盘后","latestPrice":251.2,"preClose":249.65,"latestTime":"16:49 EDT","volume":812,"amount":203902.04268,"timestamp":1790887771172,"change":1.55,"changeRate":0.006209,"amplitude":0.00701},"volumeRatio":1.352129,"impliedVol":0.9424,"impliedVolPercentile":0.6056},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2274486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.352129,"shares":2274486,"dividePrice":0.9037,"high":271.79,"amplitude":0.086008,"preClose":265.79,"low":248.93,"week52Low":93.2,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":249.65,"committee":-0.851852,"eps":0,"divideRate":0.00362,"volume":439268,"delay":0,"ttmEps":0,"open":261.76,"prevYearClose":159.39,"prevWeekClose":252.47,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":257.32,"twentyDayClose":311.81,"sixtyDayClose":317.19},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:15,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669120098","title":"AdAlta wins FDA pre‑IND meeting for lead CAR‑T cancer therapy EW‑001","url":"https://stock-news.laohu8.com/highlight/detail?id=2669120098","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669120098?lang=en_us&edition=fundamental","pubTime":"2026-09-23 06:54","pubTimestamp":1790117646,"startTime":"0","endTime":"0","summary":"The latest announcement is out from AdAlta Ltd. ( ($AU:1AD) ). AdAlta has secured acceptance from the U.S. Food and Drug Administration for a pre‑I...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adalta-wins-fda-preind-meeting-for-lead-cart-cancer-therapy-ew001?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adalta-wins-fda-preind-meeting-for-lead-cart-cancer-therapy-ew001?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669127919","title":"Health Care up as Viking Surges - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2669127919","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669127919?lang=en_us&edition=fundamental","pubTime":"2026-09-23 05:11","pubTimestamp":1790111460,"startTime":"0","endTime":"0","summary":"Health-care companies rose as one obesity-drug maker surged following a promising clinical trial.Viking Therapeutics shares jumped by roughly one-third after a study showed that patients taking its weight-loss injection could keep weight off even when switching to less frequent doses.Danish Ozempic maker Novo Nordisk wallowed around recent lows, amid concerns about intensifying competition in the popular weight-loss category.Swiss drug maker Roche said an obesity drug candidate met the main objectives of a midstage clinical trial by helping patients reduce their blood glucose and body weight.A task force commissioned by Vice President JD Vance will remove as many as 750,000 enrollments from the Affordable Care Act's public exchanges, citing enrollee ineligibility and fraud.Maze Therapeutics rallied after rival Vertex Pharmaceuticals reported positive study results for its kidney disease drug, stoking optimism about demand for kidney products.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4585","BK4588","XBI","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669273451","title":"TriSalus Life Sciences Gets FDA Clearance for Drug Delivery Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2669273451","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669273451?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:55","pubTimestamp":1790110500,"startTime":"0","endTime":"0","summary":"TriSalus Life Sciences said it received Food and Drug Administration 510 clearance for a new pressure-enabled drug delivery device.Shares surged 26% to $6.21 on the news after Tuesday's closing bell. The stock closed down 1% at $4.93 and is down 29% this year.The oncology company said the FDA greenlit TriNav Advance, the latest addition to the company's PEDD portfolio. The new device has access to small, distal vessels using a microcatheter and completes the company's portfolio addressing liver-directed therapy cases, TriSalus said.The company will launch a limited market release of the device in the coming weeks.\"TriNav Advance enhances our Pressure-Enabled Drug Delivery portfolio in support of the full range of liver embolization procedures,\" Chief Executive Mary Szela said. \"We are proud of the range of tools we offer to physicians and believe TriNav Advance will catalyze further adoption across these procedures. We're excited to broaden our portfolio in a way that can meaningfully ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","BK4139","TLSI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669876127","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2669876127","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669876127?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:50","pubTimestamp":1790110200,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0638 ET - Novo Nordisk's capital markets day announcements, incl","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","BK4581","XBI","XLV","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669687127","title":"TriSalus Gains FDA Clearance for TriNav Advance Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2669687127","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669687127?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:46","pubTimestamp":1790109964,"startTime":"0","endTime":"0","summary":"TriSalus Life Sciences ( ($TLSI) ) has shared an announcement. On September 22, 2026, TriSalus Life Sciences announced it received U.S. FDA 510(k) ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/trisalus-gains-fda-clearance-for-trinav-advance-device?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/trisalus-gains-fda-clearance-for-trinav-advance-device?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669127689","title":"Quoin Gains FDA Fast Track for QRX003 Skin Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2669127689","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669127689?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:45","pubTimestamp":1790109914,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals ( ($QNRX) ) just unveiled an announcement. On Sept. 22, 2026, Quoin Pharmaceuticals announced that the U.S. Food and Drug Adm...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/quoin-gains-fda-fast-track-for-qrx003-skin-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/quoin-gains-fda-fast-track-for-qrx003-skin-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669227331","title":"Tenet Healthcare initiated with a Market Perform at BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2669227331","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669227331?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:36","pubTimestamp":1790109391,"startTime":"0","endTime":"0","summary":"BMO Capital initiated coverage of Tenet Healthcare (THC) with a Market Perform rating and $265 price target Published first on TheFly – the ultimat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tenet-healthcare-initiated-with-a-market-perform-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tenet-healthcare-initiated-with-a-market-perform-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LU0128526141.USD","THC","LU0963586101.USD","BK4581","BK4137","LU1201861165.SGD","LU2324357040.USD","LABU","BK4585","XBI","XLV","BK4185","LU0130103400.USD","LU0648000940.SGD","LU0029874061.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669775122","title":"Tenet Healthcare Issues New Senior Notes to Refinance Debt","url":"https://stock-news.laohu8.com/highlight/detail?id=2669775122","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669775122?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:31","pubTimestamp":1790109084,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Tenet Healthcare ( ($THC) ). On September 22, 2026, Tenet Healthcare Corporation issued $2 billion of 6.250% se...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tenet-healthcare-issues-new-senior-notes-to-refinance-debt?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tenet-healthcare-issues-new-senior-notes-to-refinance-debt?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","XLV","LU0029874061.USD","LU0128526141.USD","BK4588","HCSG","BK4581","BK4585","BK4137","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669227871","title":"GE HealthCare Appoints Pascal Desroches to Board Committees","url":"https://stock-news.laohu8.com/highlight/detail?id=2669227871","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669227871?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:30","pubTimestamp":1790109033,"startTime":"0","endTime":"0","summary":"GE Healthcare Technologies Inc ( ($GEHC) ) has issued an announcement. On September 22, 2026, GE HealthCare Technologies Inc. announced that its Bo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ge-healthcare-appoints-pascal-desroches-to-board-committees?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ge-healthcare-appoints-pascal-desroches-to-board-committees?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU1093756325.SGD","LU2168564149.EUR","LU0353189680.USD","LU1066051225.USD","LU0820562030.AUD","XAR","LU1066051498.USD","LU0820561818.USD","LU1366192091.USD","UXI","LU1066051811.HKD","ITA","LU0640476718.USD","LU2543165471.USD","BK4501","BK4187","LU2756315664.SGD","LU2168564065.EUR","LU2756315318.SGD","BK4206","BK4581","TRUI","XBI","LU2168564495.EUR","LU0943347566.SGD","GE","LU2087625088.SGD","DFEN","LU0354030511.USD","LU0077335932.USD","PPA","LU1093756168.USD","LU1280957306.USD","XLV","LU0149725797.USD","LU0157215616.USD","LU0267386448.USD","NATO","LU2168564222.USD","LU0820561909.HKD","LU0868494617.USD","MISL","LU1064131342.USD","BK4543","LU0354030438.USD","LU2168563687.JPY","LU1366333091.USD","BK4566","EXI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669720122","title":"TriSalus Life Sciences receives FDA clearance for TriNav Advance","url":"https://stock-news.laohu8.com/highlight/detail?id=2669720122","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669720122?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:20","pubTimestamp":1790108439,"startTime":"0","endTime":"0","summary":"TriSalus Life Sciences (TLSI) announced it has received U.S. Food and Drug Administration 510(k) clearance for TriNav Advance, the newest addition ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/trisalus-life-sciences-receives-fda-clearance-for-trinav-advance-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/trisalus-life-sciences-receives-fda-clearance-for-trinav-advance-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","TLSI","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669512265","title":"DRI Healthcare (DHT.UN) Receives a Buy from Stifel Nicolaus","url":"https://stock-news.laohu8.com/highlight/detail?id=2669512265","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669512265?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:05","pubTimestamp":1790107533,"startTime":"0","endTime":"0","summary":"In a report released today, Justin Keywood from Stifel Nicolaus maintained a Buy rating on DRI Healthcare, with a price target of C$26.00. Accordin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/dri-healthcare-dht-un-receives-a-buy-from-stifel-nicolaus-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/dri-healthcare-dht-un-receives-a-buy-from-stifel-nicolaus-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU0029874061.USD","LU0128526141.USD","BK4137","XBI","XLV","HCSG","BK4588","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669126491","title":"Exchange-Traded Funds Rise, US Equities Mixed After Midday","url":"https://stock-news.laohu8.com/highlight/detail?id=2669126491","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669126491?lang=en_us&edition=fundamental","pubTime":"2026-09-23 01:10","pubTimestamp":1790097034,"startTime":"0","endTime":"0","summary":"Broad Market IndicatorsBroad-market exchange-traded funds IWM and IVV edged higher. Actively traded Invesco QQQ Trust (QQQ) added 0.5%.US equity indexes traded mixed, with materials leading gainers an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BITY","PSQ","CBOJ","UGL","BTCW","ETH","XAUUSD.FOREX","FBTC","CBTO","USO","ETH.USD.CC","BK4588","XLY","XRT","DULL","XSD","IAUM","NOCT","BITO","BK4550","BTCI","XBTY","BTCZ","BK4593","BETE","NAPR","YBTC","IYH","IYE","QQQM","BTCC","DGP","XLPD","SBIT","CBTA","BTF","RTH","TECL","DEFI","SCO","VIS","FAZ","CBXJ","BAR","DGZ","QQQ","BITX","CBXA","GBTC","BETH","OUNZ","BK4547","XLP","USG","EZBC","GLDY","RETL","SHNY","VDC","XLK","BTRN","SLV","ETHD","SIVR","ESK","QQQX","DFII","FGDL","VHT","SOXX","MAXI","YGLD","BRRR","BK4504","BAGY","QMAR","TETH","BITB","GLD","SQQQ","GLDM","BITU","BK4561","BTC","QID","ETCO","GPIQ","QDEC","XBI","ARKB","NDX","KGLD","BTC.USD.CC","SOXS","QBF","LABU","XAGUSD.FOREX","BPI","ZSL","CBTY","IAUI","IYJ","UNG","NJUL","CBOO","SGOL","BFAP","ETQ","MNRS","BTCL","IGM","XLF","BGLD","BCCC","CBTJ","IBB","BFJL","AGQ","SOXL","DZZ","IAU","NJAN","GLL","BITI","XLPU","CBOY","IGLD","BK4534","HODL","IYW","TQQY","BK4581","BTCO","TQQQ","XLE","EETH","QLD","IBIT","CBOA","XLI","BK4570","FAS","XLV","AAAU","UCO","CBXO","ETHT","SETH","CBXY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669126961","title":"CMS cancels 315,000 unauthorized enrollments in federal health insurance market","url":"https://stock-news.laohu8.com/highlight/detail?id=2669126961","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669126961?lang=en_us&edition=fundamental","pubTime":"2026-09-23 00:50","pubTimestamp":1790095832,"startTime":"0","endTime":"0","summary":"The Centers for Medicare & Medicaid Services announced it is taking “aggressive, sweeping actions within the Federal Marketplace – canceling approx...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cms-cancels-315000-unauthorized-enrollments-in-federal-health-insurance-market-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cms-cancels-315000-unauthorized-enrollments-in-federal-health-insurance-market-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","US10Y.BOND","BK4588","XBI","UNHU","US30Y.BOND","UN","UNHW","BK4581","IHF","BK4585","TLT","LNGR","US3Y.BOND","UNHG","TMF","XLV","TLTW","US5Y.BOND","US6M.BOND","US12M.BOND","IYH","US7Y.BOND","US2Y.BOND","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669512503","title":"Grail Gains From More Focused FDA Review Before Galleri Advisory Panel, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2669512503","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669512503?lang=en_us&edition=fundamental","pubTime":"2026-09-23 00:26","pubTimestamp":1790094370,"startTime":"0","endTime":"0","summary":"Grail  faces an \"incrementally positive\" shift toward a narrower and more focused Food and Drug Administration debate ahead of Wednesday's advisory committee meeting on Galleri, its multicancer early detection test, UBS Securities said in a report.The FDA briefing documents show the agency has no major outstanding questions about Galleri's analytical performance, bridging analyses or primary safety results, UBS said Monday in the report. Instead, the panel discussion is expected to center on how the test should be positioned and labeled.A key issue is whether Galleri's stage-specific performance supports an \"early detection\" claim and how broadly any clinical benefit should be reflected in the final indication, the report said. UBS said it still expects FDA approval.UBS reiterated its buy rating on Grail stock with a $105 price target.Price: 108.40, Change: +0.43, Percent Change: +0.40","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4585","BK4139","GRAL","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669257961","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2669257961","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669257961?lang=en_us&edition=fundamental","pubTime":"2026-09-23 00:20","pubTimestamp":1790094000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0638 ET - Novo Nordisk's capital markets day announcements, incl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","XLV","LABU","BK4588","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669757123","title":"Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN), Viking Therapeutics (VKTX) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669757123","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669757123?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:20","pubTimestamp":1790090418,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Eledon Pharmaceuticals (ELDN), Viking Therapeutics (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eledon-pharmaceuticals-eldn-viking-therapeutics-vktx-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eledon-pharmaceuticals-eldn-viking-therapeutics-vktx-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBE","LU2089984988.USD","LU2242646821.SGD","LU0128526141.USD","IE00B2B36J28.USD","LU0029874061.USD","BK4139","LU0122379950.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","HCSG","BIB","LU2468319806.SGD","BK4534","IBB","BK4588","LU0058720904.USD","IE0002141913.USD","ELDN","LU0289739699.SGD","LU1061106388.HKD","LU1571399168.USD","BK4566","IE00BFTCPJ56.SGD","LU1057294990.SGD","XLV","BBH","PJP","IE00BJJMRZ35.SGD","LU2112291526.USD","IE0009355771.USD","BK4585","LU0109394709.USD","AMGN","LU0889565916.HKD","BK4533","TBXU","BK4599","SG9999001440.SGD","LU1983299246.USD","LU2242652126.USD","BK4137","LABU","IBBQ","OZEM","VKTX","LU0868494617.USD","IE00BJT1NW94.SGD","XBI","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669128984","title":"China Isotope & Radiation Gains FDA Clearance for Lu-177 Nuclear Medicine Ingredient","url":"https://stock-news.laohu8.com/highlight/detail?id=2669128984","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669128984?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:38","pubTimestamp":1790087888,"startTime":"0","endTime":"0","summary":"China Isotope & Radiation Corp. ( ($HK:1763) ) has provided an announcement. China Isotope & Radiation Corporation has announced that its subsidiar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/china-isotope-radiation-gains-fda-clearance-for-lu-177-nuclear-medicine-ingredient?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/china-isotope-radiation-gains-fda-clearance-for-lu-177-nuclear-medicine-ingredient?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669140714","title":"Filana can proceed with study as hold lifted, says Lucid Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2669140714","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669140714?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:05","pubTimestamp":1790085948,"startTime":"0","endTime":"0","summary":"Lucid Capital analyst Elemer Piros reiterates a Buy rating on Filana Therapeutics (FLNA) with an $8 price target after the company said the FDA has...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/filana-can-proceed-with-study-as-hold-lifted-says-lucid-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/filana-can-proceed-with-study-as-hold-lifted-says-lucid-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4596","BK4588","BK4551","LCID","BK4585","BK4007","BK4099","FLNA","LABU","LCIZ","BK4555","LCDL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669474981","title":"Compass Therapeutics Faces FDA Pushback on Tovecimig Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669474981","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669474981?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:35","pubTimestamp":1790084121,"startTime":"0","endTime":"0","summary":"The latest update is out from Compass Therapeutics ( ($CMPX) ). On Sept. 22, 2026, Compass Therapeutics reported that the U.S. Food and Drug Admini...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/compass-therapeutics-faces-fda-pushback-on-tovecimig-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/compass-therapeutics-faces-fda-pushback-on-tovecimig-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CMPX","BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669714767","title":"Press Release: Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil(R) Development Amid Growing Federal Support for Botanical Drug Pathways","url":"https://stock-news.laohu8.com/highlight/detail?id=2669714767","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669714767?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:30","pubTimestamp":1790083800,"startTime":"0","endTime":"0","summary":"Initial tranche assists CannEpil(R) development and commercializationFinancing comes as FDA and Congress increase focus on advancing and incentivizing regulated development of botanical and plant-deri","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","EDVA","R","LABU","TMF","US2Y.BOND","BK4022","US7Y.BOND","TLTW","US30Y.BOND","US5Y.BOND","AAQC","TLT","US12M.BOND","US10Y.BOND","US3Y.BOND","BK4169","BK4588","US6M.BOND","BK4232"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":15,"totalSize":388,"code":"91000000","status":"200"}]}}